Insufficient scRNA-seq data for expression of GDF6 at single-cell level.
Insufficient scRNA-seq data for expression of GDF6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 86% | 70.13 | 283 / 328 | 70% | 2.16 | 124 / 178 |
bladder | 95% | 149.95 | 20 / 21 | 22% | 0.63 | 111 / 504 |
uterus | 84% | 201.18 | 143 / 170 | 30% | 1.47 | 136 / 459 |
thymus | 97% | 131.65 | 631 / 653 | 14% | 7.32 | 86 / 605 |
intestine | 91% | 127.07 | 875 / 966 | 11% | 0.36 | 58 / 527 |
esophagus | 79% | 107.68 | 1143 / 1445 | 22% | 0.37 | 41 / 183 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.11 | 1 / 1 |
breast | 76% | 82.75 | 348 / 459 | 21% | 0.53 | 237 / 1118 |
blood vessel | 94% | 159.51 | 1261 / 1335 | 0% | 0 | 0 / 0 |
stomach | 79% | 103.49 | 283 / 359 | 15% | 0.36 | 44 / 286 |
adipose | 90% | 168.17 | 1089 / 1204 | 0% | 0 | 0 / 0 |
prostate | 65% | 54.26 | 160 / 245 | 21% | 0.41 | 105 / 502 |
kidney | 27% | 15.30 | 24 / 89 | 59% | 9.19 | 532 / 901 |
heart | 77% | 214.83 | 666 / 861 | 0% | 0 | 0 / 0 |
brain | 62% | 38.44 | 1643 / 2642 | 12% | 0.35 | 85 / 705 |
lung | 44% | 29.94 | 253 / 578 | 13% | 0.70 | 154 / 1155 |
ovary | 22% | 18.42 | 40 / 180 | 26% | 0.58 | 110 / 430 |
adrenal gland | 12% | 5.51 | 31 / 258 | 33% | 1.38 | 76 / 230 |
skin | 35% | 135.53 | 638 / 1809 | 7% | 0.48 | 32 / 472 |
liver | 36% | 26.73 | 81 / 226 | 5% | 0.17 | 21 / 406 |
tonsil | 0% | 0 | 0 / 0 | 16% | 1.14 | 7 / 45 |
spleen | 11% | 6.21 | 26 / 241 | 0% | 0 | 0 / 0 |
muscle | 6% | 4.02 | 47 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.09 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001656 | Biological process | metanephros development |
GO_0006915 | Biological process | apoptotic process |
GO_0030509 | Biological process | BMP signaling pathway |
GO_1990009 | Biological process | retinal cell apoptotic process |
GO_0060395 | Biological process | SMAD protein signal transduction |
GO_0032924 | Biological process | activin receptor signaling pathway |
GO_0032332 | Biological process | positive regulation of chondrocyte differentiation |
GO_0035788 | Biological process | cell migration involved in metanephros development |
GO_0045666 | Biological process | positive regulation of neuron differentiation |
GO_0060391 | Biological process | positive regulation of SMAD protein signal transduction |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0045444 | Biological process | fat cell differentiation |
GO_1900745 | Biological process | positive regulation of p38MAPK cascade |
GO_0010631 | Biological process | epithelial cell migration |
GO_0005615 | Cellular component | extracellular space |
GO_0008083 | Molecular function | growth factor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | GDF6 |
Protein name | Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16) GDF6 protein Growth differentiation factor 6 |
Synonyms | hCG_15804 BMP13 GDF16 |
Description | FUNCTION: Growth factor that controls proliferation and cellular differentiation in the retina and bone formation. Plays a key role in regulating apoptosis during retinal development. Establishes dorsal-ventral positional information in the retina and controls the formation of the retinotectal map . Required for normal formation of bones and joints in the limbs, skull, digits and axial skeleton. Plays a key role in establishing boundaries between skeletal elements during development. Regulation of GDF6 expression seems to be a mechanism for evolving species-specific changes in skeletal structures. Seems to positively regulate differentiation of chondrogenic tissue through the growth factor receptors subunits BMPR1A, BMPR1B, BMPR2 and ACVR2A, leading to the activation of SMAD1-SMAD5-SMAD8 complex. The regulation of chondrogenic differentiation is inhibited by NOG . Also involved in the induction of adipogenesis from mesenchymal stem cells. This mechanism acts through the growth factor receptors subunits BMPR1A, BMPR2 and ACVR2A and the activation of SMAD1-SMAD5-SMAD8 complex and MAPK14/p38 (By similarity). . |
Accessions | A0A140F382 A0PK22 M1L0V3 A0A140F384 A0PK23 Q6KF10 A0A0S2A5D6 ENST00000287020.7 M1L5L6 |